Get the Stockscreener App
155.54
0.40%
-0.6916
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $155.54, with a volume of 125.73K.
It is down -0.40% in the last 24 hours and down -14.73% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$156.23
Open:
$154.67
24h Volume:
125.73K
Relative Volume:
0.05
Market Cap:
$44.27B
Revenue:
$21.92B
Net Income/Loss:
$1.76B
P/E Ratio:
25.41
EPS:
6.1223
Net Cash Flow:
$2.63B
1W Performance:
-3.73%
1M Performance:
-14.73%
6M Performance:
-16.36%
1Y Performance:
-32.10%
1-Day Range:
$154.09
$156.05
1-Week Range:
$153.75
$160.03
52-Week Range:
$153.75
$231.82
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
155.64 | 44.44B | 21.92B | 1.76B | 2.63B | 6.1223 |
ISRG
Intuitive Surgical Inc
|
470.63 | 169.79B | 10.06B | 2.88B | 2.49B | 7.876 |
ALC
Alcon Inc
|
73.43 | 36.14B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
41.81 | 34.48B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
225.33 | 33.21B | 5.40B | 1.49B | 1.78B | 10.12 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Murphy Middleton Hinkle & Parker Inc. Makes New $1.25 Million Investment in Becton, Dickinson and Company $BDX - MarketBeat
SG Americas Securities LLC Purchases 491,255 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson stock faces analyst pressure as Argus cuts price target amid Q1 earnings beat - AD HOC NEWS
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Becton Dickinson & Co stock faces analyst scrutiny as Argus cuts price target to $180 amid medtech s - AD HOC NEWS
Deals tracker: Cencora to buy ophthalmology practice for $1.1B - Modern Healthcare
Argus Lowers Becton, Dickinson and Company (NYSE:BDX) Price Target to $180.00 - MarketBeat
Argus cuts Becton Dickinson stock price target on market turbulence By Investing.com - Investing.com South Africa
Argus cuts Becton Dickinson stock price target on market turbulence - Investing.com
TABR Capital Management LLC Invests $3.81 Million in Becton, Dickinson and Company $BDX - MarketBeat
Nordea Investment Management AB Has $541.33 Million Stake in Becton, Dickinson and Company $BDX - MarketBeat
CIBC Bancorp USA Inc. Takes $7.40 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock underperforms Friday when compared to competitors - MarketWatch
ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.
Becton, Dickinson and Company Trade Ideas — LS:857675 - TradingView
184,835 Shares in Becton, Dickinson and Company $BDX Bought by Danske Bank A S - MarketBeat
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Graybill Wealth Management LTD. Raises Position in Becton, Dickinson and Company $BDX - MarketBeat
Avity Investment Management Inc. Acquires 7,107 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co (FRA:BOX) Stock Price, Trades & News - GuruFocus
Bank of Nova Scotia Lowers Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co Stock (ISIN: US0758871091) Trades at 27% Discount Amid Medtech Recovery Signal - AD HOC NEWS
Becton Dickinson gets its spinoff deal, but the stock is still falling - MSN
Clifford Capital Partners LLC Boosts Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company’s Bilal Muhsin on the future of Connected Care - Gulf Business
Quantitative Investment Management LLC Sells 42,588 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Acquired by Russell Investments Group Ltd. - MarketBeat
Becton, Dickinson and Company $BDX Position Raised by Bristol John W & Co. Inc. NY - MarketBeat
Assessing Becton Dickinson (BDX) Valuation After Recent Share Price Weakness And Planned Business Separation - simplywall.st
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Organizations urged to adopt smarter safety solutions, Becton Dickinson recommends - Traders Union
Becton, Dickinson and Company $BDX Shares Bought by Legal & General Group Plc - MarketBeat
Bank of Montreal Can Sells 17,183 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson Recieves FDA Clearance for Surgiphor 1000 ml Irrigation System - Insider Monkey
Why Is Becton Dickinson (BDX) Down 4.5% Since Last Earnings Report? - Yahoo Finance
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $198 - 富途牛牛
Becton Dickinson expands robotics offering with Sinteco to streamline pharmacy operations - Traders Union
Richard Bernstein Advisors LLC Sells 8,405 Shares of Becton, Dickinson and Company $BDX - MarketBeat
First Trust Advisors LP Has $55.52 Million Stake in Becton, Dickinson and Company $BDX - MarketBeat
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $202 - 富途牛牛
Becton Dickinson at Barclays Conference: Strategic Growth and Innovation - Investing.com
Swiss National Bank Trims Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Natixis Advisors LLC Has $57.56 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Victory Capital Management Inc. Sells 315,037 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Clarkston Capital Partners LLC Grows Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
BD Product Launches Test Infection Control Story As Shares Weaken - simplywall.st
Ex-Dividend Reminder: Ormat Technologies, Becton, Dickinson and Elevance Health - Nasdaq
BD Advances Iliac Artery Treatment Across the European Union :: Becton, Dickinson and Company (BDX) - Becton Dickinson
BD Advances Iliac Artery Treatment Across the European Union - Finviz
Becton, Dickinson and Company (BDXB) Competitors - Meyka
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):